Advaxis, Inc. announced the appointment of Molly Henderson as Executive Vice President and Chief Financial Officer, effective June 6, 2018. Ms. Henderson joins Advaxis from Cedar Cliff, LLC, where she served as a financial and business consultant to high-growth entrepreneurial companies. Previously she was Chief Financial Officer at Iovance Biotherapeutics, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3196 USD | +27.84% | +6.53% | -52.08% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-52.08% | 10.66M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- ADXS Stock
- News Ayala Pharmaceuticals, Inc.
- Advaxis, Inc. Appoints Molly Henderson as Executive Vice President and Chief Financial Officer